Back to Market返回行情
ET
ETRA Electra Therapeutics Inc.
NASDAQHealthcare$10.37-2.90%ClosedMarket Cap: $220.0M
As of 2026-10-02
Why ETRA matters now
Electra Therapeutics Inc. (ETRA) is a US stock in Healthcare. The latest InvestLog snapshot shows $10.37 with -2.90% on the session and $220.0M in market capitalization.
The latest indexable market news headline is "Electra Therapeutics (NASDAQ:ETRA) Director Carl Gordon Acquires 1,333,333 Shares of Stock" from Defense World.
Latest News
Electra Therapeutics (NASDAQ:ETRA) Director Carl Gordon Acquires 1,333,333 Shares of StockDefense World · 2026-09-24
Electra Therapeutics (NASDAQ:ETRA) Director Orbimed Advisors Llc Purchases 1,333,333 SharesDefense World · 2026-09-24
Kinzey Capital Management: Electra Sets Nasdaq IPO TermsGlobeNewsWire · 2026-09-19
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public OfferingGlobeNewsWire · 2026-09-17
Electra Therapeutics targets $977.6 million valuation in US IPOReuters · 2026-09-14
Company Info
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Exchange
NASDAQ
Beta
0.00
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.